countries News newsbot.ch

Wirtschaft »

FDA approves cobas Babesia, Roche’s first whole blood test for donor screening

2019-09-20 07:40:10


Wirtschaft »

FDA grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis

2019-09-18 05:20:01


Wirtschaft »

Roche receives FDA clearance for cobas pro integrated solutions designed to help labs deliver faster results to patients

2019-09-16 05:20:45


Wirtschaft »

Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis

2019-09-13 13:20:50


Wirtschaft »

Roche’s fixed-dose subcutaneous combination of Perjeta and Herceptin showed non-inferiority when compared to intravenous formulations for people with HER2-positive breast cancer

2019-09-13 13:20:50


Wirtschaft »

Roche’s satralizumab significantly reduced relapse risk in second  positive phase III study for neuromyelitis optica spectrum

Roche’s satralizumab significantly reduced relapse risk in second positive phase III study for neuromyelitis optica spectrum

2019-09-12 13:20:00


Wirtschaft »

Roche’s Tecentriq as a first-line monotherapy helped certain people with advanced non-small cell lung cancer live longer compared with chemotherapy

2019-09-12 13:20:00


Wirtschaft »

Roche presents new OCREVUS (ocrelizumab) biomarker data that increase understanding of disease progression in multiple sclerosis at ECTRIMS

2019-09-10 05:40:12


Wirtschaft »

European Commission approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of people with extensive-stage small cell lung cancer

2019-09-06 06:20:00


Wirtschaft »

European Commission approves Roche’s new Tecentriq-based combination therapy as an initial treatment for most common form of advanced lung cancer

2019-09-06 06:20:00


Wirtschaft »

Roche to present pivotal data for satralizumab in neuromyelitis optica spectrum disorder and six-year OCREVUS data in multiple sclerosis at ECTRIMS

2019-09-04 06:40:12


Wirtschaft »

Positive phase III results show Xofluza reduces risk of developing flu after contact with an infected person by 86%

2019-09-02 22:40:14


Wirtschaft »

Roche presents positive phase III study results for one-dose Xofluza in children with flu

2019-09-02 22:40:14


Wirtschaft »

Roche launches VENTANA PD-L1 (SP142) Assay in CE markets as first companion diagnostic to identify triple-negative breast cancer patients eligible for treatment with Tecentriq

2019-08-29 07:40:16


Wirtschaft »

European Commission approves Roche’s Tecentriq in combination with Abraxane for people with PD-L1-positive, metastatic triple-negative breast cancer

2019-08-29 07:40:16


Inland »

Georgien gilt als verfolgungssicherer Staat: Rückkehr ist grundsätzlich zumutbar

2019-08-28 11:52:21


Wirtschaft »

FDA approves Roche’s Rozlytrek (entrectinib) for people with ROS1-positive, metastatic non-small cell lung cancer and NTRK gene fusion-positive solid tumours

2019-08-16 16:40:40


Wirtschaft »

Roche’s Tecentriq plus platinum-based chemotherapy reduced the risk of disease worsening or death in people with previously untreated advanced bladder cancer

2019-08-05 05:40:23


Wirtschaft »

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

2019-07-31 09:24:45


Wirtschaft »

Roche receives CHMP positive opinion for new Tecentriq-based combination therapy as an initial treatment for most common form of advanced lung cancer

2019-07-26 11:20:11



Suchresultate als RSS-Feed